Shikiar Asset Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,018
Closed -$33K 77
2024
Q3
$33K Sell
1,018
-1,855
-65% -$103K 0.01% 74
2024
Q2
$236K Sell
2,873
-1,145
-28% -$124K 0.06% 64
2024
Q1
$582K Buy
4,018
+1,068
+36% +$90.2K 0.17% 51
2023
Q4
$272K Buy
2,950
+1,450
+97% +$147K 0.08% 63
2023
Q3
$247K Buy
+1,500
New +$195K 0.09% 68
2018
Q4
Sell
-1,850
Closed -$463K 79
2018
Q3
$463K Buy
+1,850
New +$398K 0.18% 61

Other funds holding CDLX

Shikiar Asset Management's CDLX Position: Q4 2024 in Review

Shikiar Asset Management sold out of Cardlytics (CDLX) in Q4 2024, closing a stake of 1,018 shares — an estimated $33K sold.

Shikiar Asset Management first reported a position in CDLX in Q3 2018 and held it in 6 quarters. The position peaked at $582K in Q1 2024. 108 funds tracked by Wall St. Rank hold CDLX as of Q4 2024.

  • Shikiar Asset Management reported no remaining Cardlytics position as of Q4 2024 after selling out during the quarter.
  • Shikiar Asset Management sold 1,018 Cardlytics shares in Q4 2024, an estimated $33K.
  • Shikiar Asset Management first reported a position in Cardlytics in Q3 2018 and held it in 6 quarters.
  • Shikiar Asset Management's Cardlytics position peaked at $582K in Q1 2024.
  • 108 funds tracked by Wall St. Rank held Cardlytics as of Q4 2024.

Based on Shikiar Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.